Literature DB >> 1763951

Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. Part IV: Biological evaluation--in vivo studies on the P 388 leukemia.

H Reile1, T Spruss, G Bernhardt, R Müller, R Gust, H Schönenberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1763951     DOI： 10.1002/ardp.19913240702

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN： 0365-6233            Impact factor:   3.751


× No keyword cloud information.
  2 in total

1.  Tumor-inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. V. Synthesis and evaluation of enantiomeric [1,2-bis-(4-fluorophenyl)ethylenediamine]dichloroplatinum(II) complexes.

Authors:  H D vom Orde; H Reile; R Müller; R Gust; G Bernhardt; T Spruss; H Schönenberger; T Burgemeister; A Mannschreck
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  In vitro activity of immunoconjugates between cisplatin and an anti-CA125 monoclonal antibody on ovarian cancer cell lines.

Authors:  E Beck; M Hofmann; G Bernhardt; W Jäger; L Wildt; N Lang
Journal:  Cell Biophys       Date:  1994
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.